News | December 29, 2014

Mammography Market Value in the Americas Projected Beyond $1 Billion by 2020

U.S. market will lead the way, with 3-D systems overtaking 2-D by 2016; 2-D demand to remain high in other countries

Mammography Market Value in the Americas Projected Beyond $1 Billion by 2020

December 29, 2014 — The market value of mammography systems in the Americas will increase from approximately $390 million in 2013 to $1.1 billion by 2020, according to business intelligence provider GBI Research, driven primarily by the uptake of 3-D systems in the United States and healthy demand for 2-D systems in Canada, Mexico and Brazil.

The company’s latest report states that the United States will continue to hold the dominant share, with its overall market value forecast to exceed $925 million by 2020.

Furthermore, U.S. 3-D systems revenue will rise from $99.2 million in 2013 to just over $757 million by 2020, representing a compound annual growth rate (CAGR) of 34 percent, while 2-D systems sales will decline at a negative CAGR of 4 percent.

Srikanth Venkataraman, senior analyst for GBI Research, says: “The remarkable expansion of the U.S. market will be caused by continuous replacement of 2-D systems with 3-D systems.

“The rapid adoption of 3-D systems in the United States is due to technical advantages, such as improved breast cancer detection rate, the ability to handle higher procedure volumes and a more favorable reimbursement scenario.”

U.S. sales of 3-D systems will increase year-on-year during the forecast period and will overtake the falling 2-D market in 2016. The gap will continue to widen thereafter, although the U.S. 2-D space will still be worth over $168 million by 2020, more than the entire Canadian and Mexican mammography markets combined.

GBI Research forecasts that Canada’s share will rise from $23.7 million in 2013 to $78.9 million by 2020, at a slightly faster rate than the United States, while the Mexican sector will expand from $14.8 million to $33.3 million over the same period. The Brazilian market is expected to more than triple from $14.9 million in 2013 to approximately $47 million by 2020.

Venkataraman explains: “Strong demand for 2-D systems will continue in Canada, Mexico and Brazil, as high upfront cost limits the adoption of 3-D systems in small hospitals and imaging centers with significant budget constraints.”

For more information:

Related Content

Explaining the Mammography Quality Standards Act
Feature | Mammography | October 16, 2018
The Mammography Quality Standards Act (MQSA) was enacted to improve the quality of mammography and ensure that all...
iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
"Where's My Mammogram?" Campaign Helps Women Own Breast Health Records
News | Breast Imaging | October 10, 2018
October 10, 2018 — Mammosphere launched “Where’s My Mammogram?,” a public service campaign to help women obtain copie Launches European Expansion
News | Breast Density | October 10, 2018 (DB-I) announced the launch of its international expansion for European medical providers. The...
X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection
News | Mammography | October 08, 2018
Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost...
Cullman Regional Medical Center

Cullman Regional Medical Center (Alabama) is a 145-bed medical center serving more than 175,000 residents in a six-county area and recognized as one of the region’s finest medical facilities.

Sponsored Content | Case Study | PACS | October 05, 2018
When Cullman Regional Medical Center in Alabama decided to switch from 2-D
Feature | Mammography | October 05, 2018 | By Jeff Zagoudis
“Patient-centered care” is a popular term among those in the healthcare industry in the 21st century. It means the...
Feature | Breast Imaging | October 04, 2018 | By Tracy Accardi
It has been nearly eight years since the world’s first digital breast tomosynthesis (DBT) mammography technology was...
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...